PL2229938T3 - Kompozycje ezetymibu - Google Patents
Kompozycje ezetymibuInfo
- Publication number
- PL2229938T3 PL2229938T3 PL10156084T PL10156084T PL2229938T3 PL 2229938 T3 PL2229938 T3 PL 2229938T3 PL 10156084 T PL10156084 T PL 10156084T PL 10156084 T PL10156084 T PL 10156084T PL 2229938 T3 PL2229938 T3 PL 2229938T3
- Authority
- PL
- Poland
- Prior art keywords
- ezetimibe
- methods
- pharmaceutically acceptable
- ezetimibe compositions
- compositions
- Prior art date
Links
- OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 title abstract 2
- 229960000815 ezetimibe Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Dental Preparations (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR200901961 | 2009-03-13 | ||
| EP10156084A EP2229938B9 (en) | 2009-03-13 | 2010-03-10 | Ezetimibe compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2229938T3 true PL2229938T3 (pl) | 2012-09-28 |
Family
ID=41064574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10156084T PL2229938T3 (pl) | 2009-03-13 | 2010-03-10 | Kompozycje ezetymibu |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9095515B2 (pl) |
| EP (1) | EP2229938B9 (pl) |
| AT (1) | ATE536172T1 (pl) |
| ES (1) | ES2382773T3 (pl) |
| PL (1) | PL2229938T3 (pl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012060847A1 (en) | 2010-11-07 | 2012-05-10 | Targegen, Inc. | Compositions and methods for treating myelofibrosis |
| EP2468258A1 (en) * | 2010-12-22 | 2012-06-27 | LEK Pharmaceuticals d.d. | Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient |
| CN103655481A (zh) * | 2012-09-18 | 2014-03-26 | 江苏柯菲平医药有限公司 | 一种依折麦布口服制剂制备方法 |
| HUE051406T2 (hu) | 2012-11-14 | 2021-03-01 | Grace W R & Co | Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók |
| CN104161752B (zh) * | 2013-05-16 | 2018-09-07 | 江苏豪森药业集团有限公司 | 一种维格列汀组合物 |
| KR20150079373A (ko) | 2013-12-30 | 2015-07-08 | 한미약품 주식회사 | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 |
| WO2016149191A1 (en) | 2015-03-13 | 2016-09-22 | Esperion Therapeutics, Inc. | Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease |
| MA41793A (fr) | 2015-03-16 | 2018-01-23 | Esperion Therapeutics Inc | Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire |
| US20180338922A1 (en) * | 2017-05-26 | 2018-11-29 | Esperion Therapeutics, Inc. | Fixed dose formulations |
| EP3437636A1 (en) | 2017-08-02 | 2019-02-06 | Adamed sp. z o.o. | Pharmaceutical composition comprising ezetimibe |
| CN109718215A (zh) * | 2017-10-30 | 2019-05-07 | 海南皇隆制药股份有限公司 | 一种依折麦布片 |
| EP3588150A1 (en) | 2018-06-29 | 2020-01-01 | Thomson Licensing | An optical device comprising multi-layer waveguides |
| EP3591700A1 (en) | 2018-07-02 | 2020-01-08 | Thomson Licensing | Image sensor comprising a color splitter with two different refractive indexes, and different height |
| EP3671310A1 (en) | 2018-12-18 | 2020-06-24 | Thomson Licensing | Optical manipulation apparatus for trapping or moving micro or nanoparticles |
| EP3671322A1 (en) | 2018-12-18 | 2020-06-24 | Thomson Licensing | Device for forming an outgoing electromagnetic wave from an incident electromagnetic wave |
| EP3671293A1 (en) | 2018-12-21 | 2020-06-24 | Thomson Licensing | An optical device comprising at least one diffraction grating having a grating pitch above the wavelength |
| BR112022009066A2 (pt) * | 2019-11-12 | 2022-08-09 | Univ South Africa | Ezetimiba para uso em tratamento de câncer |
| CN115252565B (zh) * | 2022-05-30 | 2023-09-19 | 国药集团致君（深圳）制药有限公司 | 一种依折麦布片及其制备工艺和溶出评价方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5631365A (en) | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| SI1413331T1 (sl) | 2001-01-26 | 2008-02-29 | Schering Corp | Kombinacije fenofibrata peroksisomskega proliferator aktivirajocega receptorja (PPAR) z ezetimib zaviralcem absorpcije sterola za vaskularne indikacije |
| JP2009529055A (ja) * | 2006-03-06 | 2009-08-13 | テバ ファーマシューティカル インダストリーズ リミティド | エゼチミベ組成物 |
| US20070275052A1 (en) | 2006-05-24 | 2007-11-29 | Glenmark Pharmaceuticals Limited | Pharmaceutical compositions containing sterol inhibitors |
| EP2120882A2 (en) | 2007-02-23 | 2009-11-25 | Krka | Pharmaceutical composition containing a cholesterol absorption inhibitor |
-
2010
- 2010-03-10 AT AT10156084T patent/ATE536172T1/de active
- 2010-03-10 PL PL10156084T patent/PL2229938T3/pl unknown
- 2010-03-10 ES ES10156084T patent/ES2382773T3/es active Active
- 2010-03-10 EP EP10156084A patent/EP2229938B9/en active Active
- 2010-03-15 US US12/723,808 patent/US9095515B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2229938B9 (en) | 2012-04-25 |
| US20100234342A1 (en) | 2010-09-16 |
| ES2382773T3 (es) | 2012-06-13 |
| ATE536172T1 (de) | 2011-12-15 |
| US9095515B2 (en) | 2015-08-04 |
| EP2229938A1 (en) | 2010-09-22 |
| EP2229938B1 (en) | 2011-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2229938T3 (pl) | Kompozycje ezetymibu | |
| EP4663636A3 (en) | Trifluoromethyl substituted pyrazoles as human plasma kallikrein inhibitors | |
| GEP20084439B (en) | Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof | |
| MY187047A (en) | Selective pyy compounds and uses thereof | |
| MX2012007375A (es) | 3-ceto-n-propargil 1-aminoindano. | |
| MX390302B (es) | Oxiesteroles y metodos de uso de los mismos | |
| EP4342540A3 (en) | Substituted heterocyclyl derivatives as cdk inhibitors | |
| WO2007135529A3 (en) | Azabenzimidazolyl compounds as mglur2 potentiators | |
| EP4616908A3 (en) | Oxysterols and methods of use thereof | |
| IN2012DN01233A (pl) | ||
| MX2014000341A (es) | Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades. | |
| MX2020010690A (es) | Oxiesteroles y metodos de uso de los mismos. | |
| WO2007027527A3 (en) | Isoindole-imide compounds and compositions comprising and methods of using the same | |
| HK1255500A1 (zh) | 氧固醇及其使用方法 | |
| MX348823B (es) | Formulaciones estables de linaclotida. | |
| GEP20186892B (en) | 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease | |
| WO2009140341A3 (en) | Atorvastatin compositions | |
| GEP20186880B (en) | 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease | |
| WO2013040227A3 (en) | Therapeutic compounds | |
| PH12017500029A1 (en) | 4,5-dihydroisoxazole derivatives as nampt inhibitors | |
| TN2012000105A1 (en) | Spirolactam derivatives and uses of same | |
| WO2014033526A9 (en) | Pharmaceutical compositions of etoricoxib | |
| WO2010046932A3 (en) | Extended release pharmaceutical composition of minocycline and process thereof | |
| WO2016006975A3 (en) | Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof | |
| WO2016006974A3 (en) | Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof |